✦ LIBER ✦

Ribonucleotide reductase M2 subunit as novel target for liposarcoma

✍ Scribed by Rula C. Geha; Vicotria Wu; Penelope DeCarolis; Rachael O’Connor; JinHong Chen; Gary Schwartz; Samuel Singer

Book ID: 113677362
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 48 KB
Volume: 203
Category: Article
ISSN: 1072-7515
DOI: 10.1016/j.jamcollsurg.2006.05.225

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ribonucleotide reductase M2 subunit is a

Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer

✍ Teppei Morikawa; Daichi Maeda; Haruki Kume; Yukio Homma; Masashi Fukayama 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 900 KB

M2 subunit of ribonucleotide reductase i

M2 subunit of ribonucleotide reductase is a target of cyclic AMP-dependent protein kinase

✍ Daniel A. Albert; Edwardine Nodzenski 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 840 KB

Cyclic AMP arrests T lymphocytes in the G1 phase of the cell cycle, and prolonged exposure results in cytolysis. Both of these effects require cyclic AMP-dependent protein kinase. We recently observed that some S49 mouse T lymphoma cell lines selected for hydroxyurea resistance were not arrested in

Retrovirally mediated RNA interference t

Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer

✍ Mark S. Duxbury; Hiromichi Ito; Eric Benoit; Michael J. Zinner; Stanley W. Ashle 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 404 KB

RNA interference targeting the M2 subuni

RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine

✍ Duxbury, Mark S; Ito, Hiromichi; Zinner, Michael J; Ashley, Stanley W; Whang, Ed 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 355 KB

Thioredoxin reductase as a novel molecul

Thioredoxin reductase as a novel molecular target for cancer therapy

✍ Phuongmai Nguyen; Rania T. Awwad; Dee Dee K. Smart; Douglas R. Spitz; David Gius 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Can ribonucleotide reductase be consider

Can ribonucleotide reductase be considered as an effective target for developing antiherpes simplex virus type II (HSV-2) compounds?

✍ Louise M. Nutter; Susan P. Grill; Yung-Chi Cheng 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 376 KB